First Trust NYSE Arca Biotechnology Index Fund
116 hedge funds and large institutions have $447M invested in First Trust NYSE Arca Biotechnology Index Fund in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.25% less ownership
Funds ownership: 39.02% → 38.77% (-0.25%)
5% less call options, than puts
Call options by funds: $2.24M | Put options by funds: $2.37M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
116
Holding in Top 10
3
Calls
$2.24M
Puts
$2.37M
Top Buyers
| 1 | +$6.91M | |
| 2 | +$5.83M | |
| 3 | +$4.28M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.99M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.93M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$3.62M | |
| 3 | -$2.73M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.67M |
| 5 |
HH
Hilltop Holdings
Dallas,
Texas
|
-$1.24M |